NASDAQ

Nektar Therapeutics (NKTR)

♥ 682 Thanks from members

Live price chart, market sentiment, and community perspectives for Nektar Therapeutics (NASDAQ: NKTR).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: John S. PattonFounder: Nektar ManagementLeadership: Howard W. Robin (President and CEO)Leadership: Jonathan H. Roberts (CFO)Holder: Vanguard Group, Inc.Holder: Baker Bros. AdvisorsHolder: BlackRock, Inc.NKTR-255PEGylated Drug ConjugatesImmunotherapy Pipeline#Nektar Therapeutics#NKTR stock#biotech clinical trials#immunotherapy#NASDAQ NKTR